Eton Pharmaceuticals Announces Initiation of Clinical Study for Product Candidate ET-700
Eton Pharmaceuticals, Inc. (ETON)
Last eton pharmaceuticals, inc. earnings: 3/5 04:02 pm
Check Earnings Report
Company Research
Source: GlobeNewswire
DEER PARK, Ill., April 27, 2026 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or “the Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced the first patient has been dosed in a pilot clinical study assessing the efficacy of ET-700, the Company’s proprietary, patent-pending formulation of extended-release zinc acetate under development for the treatment of Wilson disease. Topline study results are expected in the second half of 2026, and if positive, would lead to a pivotal clinical study in early 2027. “ET-700 has the potential to deliver a major advancement for patients with Wilson disease, and we’re excited to initiate this clinical study. Based on feedback from the patient community and treating physicians, there remains a meaningful need for more convenient, simpler dosing approaches for this lifelong chronic therapy, which ET-700 is designed to explore. If approved, we bel
Show less
Read more
Impact Snapshot
Event Time:
ETON
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ETON alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ETON alerts
High impacting Eton Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
ETON
News
- Eton Pharmaceuticals (ETON) Appoints Judith M. Matthews as New CFO [Yahoo! Finance]Yahoo! Finance
- Eton Pharmaceuticals (ETON) was downgraded by Zacks Research from "strong-buy" to "hold".MarketBeat
- How The Hemangeol Deal Is Reframing The Eton Pharmaceuticals (ETON) Investment Story [Yahoo! Finance]Yahoo! Finance
- Eton Pharmaceuticals Announces CFO Succession PlanGlobeNewswire
- How The Eton Pharmaceuticals (ETON) Story Is Shifting With Hemangeol And New Valuation Targets [Yahoo! Finance]Yahoo! Finance
ETON
Earnings
- 3/19/26 - Beat
ETON
Sec Filings
- 4/27/26 - Form 8-K
- 4/24/26 - Form DEF
- 4/22/26 - Form 4
- ETON's page on the SEC website